Jane Street Group, LLC Medicinova Inc Transaction History

Jane Street Group, LLC

$444 Billion
Q4 2024

A detailed history of Jane Street Group, LLC transactions in Medicinova Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 23,259 shares of MNOV stock, worth $40,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,259

Previous 14,138 64.51%

Holding current value

$40,470

Previous $29,000 65.52%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.53 - $2.38 $13,955 - $21,707	9,121 Added 64.51%	23,259 $48,000
Q3 2024 Nov 14, 2024	BUY	$1.13 - $2.1 $15,975 - $29,689	14,138 New	14,138 $29,000
Q1 2024 May 15, 2024	SELL	$1.28 - $1.65 $3,560 - $4,590	-2,782 Reduced 19.39%	11,563 $16,000
Q4 2023 Feb 14, 2024	BUY	$1.38 - $2.06 $19,796 - $29,550	14,345 New	14,345 $21,000
Q1 2023 May 15, 2023	SELL	$1.95 - $2.54 $420,421 - $547,626	-215,601 Reduced 80.5%	52,223 $112,000
Q4 2022 Feb 14, 2023	BUY	$1.97 - $2.66 $527,613 - $712,411	267,824 New	267,824 $549,000
Q1 2022 May 17, 2022	SELL	$2.19 - $2.81 $64,696 - $83,013	-29,542 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$2.61 - $4.42 $77,104 - $130,575	29,542 New	29,542 $79,000
Q3 2021 Nov 16, 2021	SELL	$3.4 - $4.24 $280,948 - $350,359	-82,632 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.76 - $5.14 $170,583 - $233,191	-45,368 Reduced 35.44%	82,632 $352,000
Q1 2021 May 18, 2021	BUY	$4.81 - $8.74 $488,695 - $887,984	101,600 Added 384.85%	128,000 $647,000
Q4 2020 Feb 17, 2021	SELL	$5.03 - $6.31 $15,090 - $18,930	-3,000 Reduced 10.2%	26,400 $139,000
Q3 2020 Nov 17, 2020	BUY	$4.67 - $11.0 $137,298 - $323,400	29,400 New	29,400 $154,000
Q2 2020 Aug 17, 2020	SELL	$3.06 - $7.06 $94,248 - $217,448	-30,800 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.9 - $6.97 $16,530 - $39,729	5,700 Added 22.71%	30,800 $115,000
Q4 2019 Feb 14, 2020	BUY	$6.48 - $8.76 $43,416 - $58,692	6,700 Added 36.41%	25,100 $169,000
Q3 2019 Nov 14, 2019	SELL	$7.7 - $10.42 $27,720 - $37,512	-3,600 Reduced 16.36%	18,400 $146,000
Q2 2019 Aug 15, 2019	BUY	$8.29 - $13.22 $182,379 - $290,840	22,000 New	22,000 $212,000
Q4 2018 Feb 15, 2019	SELL	$7.65 - $12.83 $159,885 - $268,147	-20,900 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.06 - $12.49 $62,128 - $109,912	8,800 Added 72.73%	20,900 $261,000
Q2 2018 Aug 15, 2018	SELL	$7.96 - $13.23 $662,447 - $1.1 Million	-83,222 Reduced 87.31%	12,100 $97,000
Q1 2018 May 15, 2018	BUY	$6.6 - $13.91 $629,125 - $1.33 Million	95,322 New	95,322 $974,000
Q4 2017 Feb 15, 2018	SELL	$5.89 - $7.21 $109,554 - $134,106	-18,600 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.43 - $6.58 $82,398 - $122,388	18,600	18,600 $118,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

5.13M

Call Options Held

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $85.3M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Medicinova Inc Transaction History